Evidence map›Paper›PMID 38881887›Full record

ReviewFrontiers in immunology2024

The function of CD36 in

Jianjun Wang, Hui Cao, Hongwei Yang, Nan Wang, Yiwei Weng, Hao Luo

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Frontiers in immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Virulence · 2026
    Article
  3. Article
  4. Innate immune recognition ofCell surface (Amsterdam, Netherlands) · 2025
    Review
  5. Journal of medical microbiology · 2025
    Article
  6. Review
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jianjun Wang *Department of Clinical Laboratory, Kunshan Hospital Affiliated to Jiangsu University, Suzhou, China.
Hui Cao *Department of Food and Nutrition Safety, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, Jiangsu, China.
Hongwei Yang *Department of Clinical Laboratory, Suzhou BOE Hospital, Suzhou, Jiangsu, China.
Nan WangDepartment of Clinical Laboratory, Kunshan Hospital Affiliated to Jiangsu University, Suzhou, China.
Yiwei WengDepartment of Clinical Laboratory, The Fourth People's Hospital of Kunshan, Suzhou, Jiangsu, China.
Hao LuoDepartment of Clinical Laboratory, The Second People's Hospital of Kunshan, Suzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

CD36 is a scavenger receptor that has been reported to function as a signaling receptor that responds to pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs) and could integrate metabolic pathways and cell signaling through its dual functions. Thereby influencing activation to regulate the immune response and immune cell differentiation. Recent studies have revealed that CD36 plays critical roles in the process of lipid metabolism, inflammatory response and immune process caused by

Indexed as

CD36 AntigensMycobacterium tuberculosisTuberculosisAnimalsBiomarkersHost-Pathogen InteractionsHumansLipid MetabolismSignal TransductionBiomarkersCD36 AntigensCD36 protein, humanbiomarkerCD36immune responseinflammatory responselipid metabolismMycobacterium tuberculosis

Identifiers

PMID38881887
PMCPMC11176518

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.